 | • レポートコード：GIR-107A02573 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学＆材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、Cディフィシル感染症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。Cディフィシル感染症治療薬の種類別市場規模（メトロニダゾール、バンコマイシン、フィダキソマイシン、その他）、用途別市場規模（前処理、中期処理、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・Cディフィシル感染症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Astellas、Eli Lilly、ANI Pharmaceutical、Flynn Pharma、Aspen Pharmacare、Akorn、Merus labs、Pfizer、AstraZeneca、Strides、Sanofi、Fresenius、Xellia、Zhejiang Medicine、Lupin ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：メトロニダゾール、バンコマイシン、フィダキソマイシン、その他 ・用途別分析2016年-2026年：前処理、中期処理、その他 ・Cディフィシル感染症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・Cディフィシル感染症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・Cディフィシル感染症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・Cディフィシル感染症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・Cディフィシル感染症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The C Difficile Infection Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global C Difficile Infection Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global C Difficile Infection Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
C Difficile Infection Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Metronidazole
Vancomycin
Fidaxomycin
Others
Market segment by Application can be divided into
Pre-treatment
Mid-term treatment
Others
The key market players for global C Difficile Infection Drug market are listed below:
Merck
Astellas
Eli Lilly
ANI Pharmaceutical
Flynn Pharma
Aspen Pharmacare
Akorn
Merus labs
Pfizer
AstraZeneca
Strides
Sanofi
Fresenius
Xellia
Zhejiang Medicine
Lupin
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe C Difficile Infection Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of C Difficile Infection Drug, with price, sales, revenue and global market share of C Difficile Infection Drug from 2019 to 2021.
Chapter 3, the C Difficile Infection Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the C Difficile Infection Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and C Difficile Infection Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe C Difficile Infection Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 C Difficile Infection Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global C Difficile Infection Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Metronidazole
1.2.3 Vancomycin
1.2.4 Fidaxomycin
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global C Difficile Infection Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pre-treatment
1.3.3 Mid-term treatment
1.3.4 Others
1.4 Global C Difficile Infection Drug Market Size & Forecast
1.4.1 Global C Difficile Infection Drug Sales in Value (2016-2026))
1.4.2 Global C Difficile Infection Drug Sales in Volume (2016-2026)
1.4.3 Global C Difficile Infection Drug Price by Type (2016-2026) & (US$/Ton)
1.5 Global C Difficile Infection Drug Production Capacity Analysis
1.5.1 Global C Difficile Infection Drug Total Production Capacity (2016-2026)
1.5.2 Global C Difficile Infection Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 C Difficile Infection Drug Market Drivers
1.6.2 C Difficile Infection Drug Market Restraints
1.6.3 C Difficile Infection Drug Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck C Difficile Infection Drug Product and Services
2.1.4 Merck C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Astellas
2.2.1 Astellas Details
2.2.2 Astellas Major Business
2.2.3 Astellas C Difficile Infection Drug Product and Services
2.2.4 Astellas C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly C Difficile Infection Drug Product and Services
2.3.4 Eli Lilly C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 ANI Pharmaceutical
2.4.1 ANI Pharmaceutical Details
2.4.2 ANI Pharmaceutical Major Business
2.4.3 ANI Pharmaceutical C Difficile Infection Drug Product and Services
2.4.4 ANI Pharmaceutical C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Flynn Pharma
2.5.1 Flynn Pharma Details
2.5.2 Flynn Pharma Major Business
2.5.3 Flynn Pharma C Difficile Infection Drug Product and Services
2.5.4 Flynn Pharma C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Aspen Pharmacare
2.6.1 Aspen Pharmacare Details
2.6.2 Aspen Pharmacare Major Business
2.6.3 Aspen Pharmacare C Difficile Infection Drug Product and Services
2.6.4 Aspen Pharmacare C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Akorn
2.7.1 Akorn Details
2.7.2 Akorn Major Business
2.7.3 Akorn C Difficile Infection Drug Product and Services
2.7.4 Akorn C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Merus labs
2.8.1 Merus labs Details
2.8.2 Merus labs Major Business
2.8.3 Merus labs C Difficile Infection Drug Product and Services
2.8.4 Merus labs C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer C Difficile Infection Drug Product and Services
2.9.4 Pfizer C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca C Difficile Infection Drug Product and Services
2.10.4 AstraZeneca C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Strides
2.11.1 Strides Details
2.11.2 Strides Major Business
2.11.3 Strides C Difficile Infection Drug Product and Services
2.11.4 Strides C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Sanofi
2.12.1 Sanofi Details
2.12.2 Sanofi Major Business
2.12.3 Sanofi C Difficile Infection Drug Product and Services
2.12.4 Sanofi C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Fresenius
2.13.1 Fresenius Details
2.13.2 Fresenius Major Business
2.13.3 Fresenius C Difficile Infection Drug Product and Services
2.13.4 Fresenius C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Xellia
2.14.1 Xellia Details
2.14.2 Xellia Major Business
2.14.3 Xellia C Difficile Infection Drug Product and Services
2.14.4 Xellia C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Zhejiang Medicine
2.15.1 Zhejiang Medicine Details
2.15.2 Zhejiang Medicine Major Business
2.15.3 Zhejiang Medicine C Difficile Infection Drug Product and Services
2.15.4 Zhejiang Medicine C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Lupin
2.16.1 Lupin Details
2.16.2 Lupin Major Business
2.16.3 Lupin C Difficile Infection Drug Product and Services
2.16.4 Lupin C Difficile Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 C Difficile Infection Drug Sales by Manufacturer
3.1 Global C Difficile Infection Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global C Difficile Infection Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in C Difficile Infection Drug
3.4 Market Concentration Rate
3.4.1 Top 3 C Difficile Infection Drug Manufacturer Market Share
3.4.2 Top 6 C Difficile Infection Drug Manufacturer Market Share
3.5 Global C Difficile Infection Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and C Difficile Infection Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global C Difficile Infection Drug Market Size by Region
4.1.1 Global C Difficile Infection Drug Sales in Volume by Region (2016-2026)
4.1.2 Global C Difficile Infection Drug Revenue by Region (2016-2026)
4.2 North America C Difficile Infection Drug Revenue (2016-2026)
4.3 Europe C Difficile Infection Drug Revenue (2016-2026)
4.4 Asia-Pacific C Difficile Infection Drug Revenue (2016-2026)
4.5 South America C Difficile Infection Drug Revenue (2016-2026)
4.6 Middle East and Africa C Difficile Infection Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global C Difficile Infection Drug Sales in Volume by Type (2016-2026)
5.2 Global C Difficile Infection Drug Revenue by Type (2016-2026)
5.3 Global C Difficile Infection Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global C Difficile Infection Drug Sales in Volume by Application (2016-2026)
6.2 Global C Difficile Infection Drug Revenue by Application (2016-2026)
6.3 Global C Difficile Infection Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America C Difficile Infection Drug Sales by Type (2016-2026)
7.2 North America C Difficile Infection Drug Sales by Application (2016-2026)
7.3 North America C Difficile Infection Drug Market Size by Country
7.3.1 North America C Difficile Infection Drug Sales in Volume by Country (2016-2026)
7.3.2 North America C Difficile Infection Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe C Difficile Infection Drug Sales by Type (2016-2026)
8.2 Europe C Difficile Infection Drug Sales by Application (2016-2026)
8.3 Europe C Difficile Infection Drug Market Size by Country
8.3.1 Europe C Difficile Infection Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe C Difficile Infection Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific C Difficile Infection Drug Sales by Type (2016-2026)
9.2 Asia-Pacific C Difficile Infection Drug Sales by Application (2016-2026)
9.3 Asia-Pacific C Difficile Infection Drug Market Size by Region
9.3.1 Asia-Pacific C Difficile Infection Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific C Difficile Infection Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America C Difficile Infection Drug Sales by Type (2016-2026)
10.2 South America C Difficile Infection Drug Sales by Application (2016-2026)
10.3 South America C Difficile Infection Drug Market Size by Country
10.3.1 South America C Difficile Infection Drug Sales in Volume by Country (2016-2026)
10.3.2 South America C Difficile Infection Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa C Difficile Infection Drug Sales by Type (2016-2026)
11.2 Middle East & Africa C Difficile Infection Drug Sales by Application (2016-2026)
11.3 Middle East & Africa C Difficile Infection Drug Market Size by Country
11.3.1 Middle East & Africa C Difficile Infection Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa C Difficile Infection Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 C Difficile Infection Drug Typical Distributors
12.3 C Difficile Infection Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global C Difficile Infection Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global C Difficile Infection Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck C Difficile Infection Drug Product and Services
Table 6. Merck C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Astellas Basic Information, Manufacturing Base and Competitors
Table 8. Astellas Major Business
Table 9. Astellas C Difficile Infection Drug Product and Services
Table 10. Astellas C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lilly Major Business
Table 13. Eli Lilly C Difficile Infection Drug Product and Services
Table 14. Eli Lilly C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. ANI Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. ANI Pharmaceutical Major Business
Table 17. ANI Pharmaceutical C Difficile Infection Drug Product and Services
Table 18. ANI Pharmaceutical C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Flynn Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Flynn Pharma Major Business
Table 21. Flynn Pharma C Difficile Infection Drug Product and Services
Table 22. Flynn Pharma C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Aspen Pharmacare Basic Information, Manufacturing Base and Competitors
Table 24. Aspen Pharmacare Major Business
Table 25. Aspen Pharmacare C Difficile Infection Drug Product and Services
Table 26. Aspen Pharmacare C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Akorn Basic Information, Manufacturing Base and Competitors
Table 28. Akorn Major Business
Table 29. Akorn C Difficile Infection Drug Product and Services
Table 30. Akorn C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merus labs Basic Information, Manufacturing Base and Competitors
Table 32. Merus labs Major Business
Table 33. Merus labs C Difficile Infection Drug Product and Services
Table 34. Merus labs C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Pfizer Basic Information, Manufacturing Base and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer C Difficile Infection Drug Product and Services
Table 38. Pfizer C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 40. AstraZeneca Major Business
Table 41. AstraZeneca C Difficile Infection Drug Product and Services
Table 42. AstraZeneca C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Strides Basic Information, Manufacturing Base and Competitors
Table 44. Strides Major Business
Table 45. Strides C Difficile Infection Drug Product and Services
Table 46. Strides C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Sanofi Basic Information, Manufacturing Base and Competitors
Table 48. Sanofi Major Business
Table 49. Sanofi C Difficile Infection Drug Product and Services
Table 50. Sanofi C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Fresenius Basic Information, Manufacturing Base and Competitors
Table 52. Fresenius Major Business
Table 53. Fresenius C Difficile Infection Drug Product and Services
Table 54. Fresenius C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Xellia Basic Information, Manufacturing Base and Competitors
Table 56. Xellia Major Business
Table 57. Xellia C Difficile Infection Drug Product and Services
Table 58. Xellia C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Zhejiang Medicine Basic Information, Manufacturing Base and Competitors
Table 60. Zhejiang Medicine Major Business
Table 61. Zhejiang Medicine C Difficile Infection Drug Product and Services
Table 62. Zhejiang Medicine C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Lupin Basic Information, Manufacturing Base and Competitors
Table 64. Lupin Major Business
Table 65. Lupin C Difficile Infection Drug Product and Services
Table 66. Lupin C Difficile Infection Drug Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global C Difficile Infection Drug Sales by Manufacturer (2019-2021e) & (Kiloton)
Table 68. Global C Difficile Infection Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in C Difficile Infection Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global C Difficile Infection Drug Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 71. Head Office and C Difficile Infection Drug Production Site of Key Manufacturer
Table 72. C Difficile Infection Drug New Entrant and Capacity Expansion Plans
Table 73. C Difficile Infection Drug Mergers & Acquisitions in the Past Five Years
Table 74. Global C Difficile Infection Drug Sales by Region (2016-2021e) & (Kiloton)
Table 75. Global C Difficile Infection Drug Sales by Region (2021-2026) & (Kiloton)
Table 76. Global C Difficile Infection Drug Revenue by Region (2016-2021e) & (USD Million)
Table 77. Global C Difficile Infection Drug Revenue by Region (2021-2026) & (USD Million)
Table 78. Global C Difficile Infection Drug Sales by Type (2016-2021e) & (Kiloton)
Table 79. Global C Difficile Infection Drug Sales by Type (2021-2026) & (Kiloton)
Table 80. Global C Difficile Infection Drug Revenue by Type (2016-2021e) & (USD Million)
Table 81. Global C Difficile Infection Drug Revenue by Type (2021-2026) & (USD Million)
Table 82. Global C Difficile Infection Drug Price by Type (2016-2021e) & (US$/Ton)
Table 83. Global C Difficile Infection Drug Price by Type (2021-2026) & (US$/Ton)
Table 84. Global C Difficile Infection Drug Sales by Application (2016-2021e) & (Kiloton)
Table 85. Global C Difficile Infection Drug Sales by Application (2021-2026) & (Kiloton)
Table 86. Global C Difficile Infection Drug Revenue by Application (2016-2021e) & (USD Million)
Table 87. Global C Difficile Infection Drug Revenue by Application (2021-2026) & (USD Million)
Table 88. Global C Difficile Infection Drug Price by Application (2016-2021e) & (US$/Ton)
Table 89. Global C Difficile Infection Drug Price by Application (2021-2026) & (US$/Ton)
Table 90. North America C Difficile Infection Drug Sales by Country (2016-2021e) & (Kiloton)
Table 91. North America C Difficile Infection Drug Sales by Country (2021-2026) & (Kiloton)
Table 92. North America C Difficile Infection Drug Revenue by Country (2016-2021e) & (USD Million)
Table 93. North America C Difficile Infection Drug Revenue by Country (2021-2026) & (USD Million)
Table 94. North America C Difficile Infection Drug Sales by Type (2016-2021e) & (Kiloton)
Table 95. North America C Difficile Infection Drug Sales by Type (2021-2026) & (Kiloton)
Table 96. North America C Difficile Infection Drug Sales by Application (2016-2021e) & (Kiloton)
Table 97. North America C Difficile Infection Drug Sales by Application (2021-2026) & (Kiloton)
Table 98. Europe C Difficile Infection Drug Sales by Country (2016-2021e) & (Kiloton)
Table 99. Europe C Difficile Infection Drug Sales by Country (2021-2026) & (Kiloton)
Table 100. Europe C Difficile Infection Drug Revenue by Country (2016-2021e) & (USD Million)
Table 101. Europe C Difficile Infection Drug Revenue by Country (2021-2026) & (USD Million)
Table 102. Europe C Difficile Infection Drug Sales by Type (2016-2021e) & (Kiloton)
Table 103. Europe C Difficile Infection Drug Sales by Type (2021-2026) & (Kiloton)
Table 104. Europe C Difficile Infection Drug Sales by Application (2016-2021e) & (Kiloton)
Table 105. Europe C Difficile Infection Drug Sales by Application (2021-2026) & (Kiloton)
Table 106. Asia-Pacific C Difficile Infection Drug Sales by Region (2016-2021e) & (Kiloton)
Table 107. Asia-Pacific C Difficile Infection Drug Sales by Region (2021-2026) & (Kiloton)
Table 108. Asia-Pacific C Difficile Infection Drug Revenue by Region (2016-2021e) & (USD Million)
Table 109. Asia-Pacific C Difficile Infection Drug Revenue by Region (2021-2026) & (USD Million)
Table 110. Asia-Pacific C Difficile Infection Drug Sales by Type (2016-2021e) & (Kiloton)
Table 111. Asia-Pacific C Difficile Infection Drug Sales by Type (2021-2026) & (Kiloton)
Table 112. Asia-Pacific C Difficile Infection Drug Sales by Application (2016-2021e) & (Kiloton)
Table 113. Asia-Pacific C Difficile Infection Drug Sales by Application (2021-2026) & (Kiloton)
Table 114. South America C Difficile Infection Drug Sales by Country (2016-2021e) & (Kiloton)
Table 115. South America C Difficile Infection Drug Sales by Country (2021-2026) & (Kiloton)
Table 116. South America C Difficile Infection Drug Revenue by Country (2016-2021e) & (USD Million)
Table 117. South America C Difficile Infection Drug Revenue by Country (2021-2026) & (USD Million)
Table 118. South America C Difficile Infection Drug Sales by Type (2016-2021e) & (Kiloton)
Table 119. South America C Difficile Infection Drug Sales by Type (2021-2026) & (Kiloton)
Table 120. South America C Difficile Infection Drug Sales by Application (2016-2021e) & (Kiloton)
Table 121. South America C Difficile Infection Drug Sales by Application (2021-2026) & (Kiloton)
Table 122. Middle East & Africa C Difficile Infection Drug Sales by Country (2016-2021e) & (Kiloton)
Table 123. Middle East & Africa C Difficile Infection Drug Sales by Country (2021-2026) & (Kiloton)
Table 124. Middle East & Africa C Difficile Infection Drug Revenue by Country (2016-2021e) & (USD Million)
Table 125. Middle East & Africa C Difficile Infection Drug Revenue by Country (2021-2026) & (USD Million)
Table 126. Middle East & Africa C Difficile Infection Drug Sales by Type (2016-2021e) & (Kiloton)
Table 127. Middle East & Africa C Difficile Infection Drug Sales by Type (2021-2026) & (Kiloton)
Table 128. Middle East & Africa C Difficile Infection Drug Sales by Application (2016-2021e) & (Kiloton)
Table 129. Middle East & Africa C Difficile Infection Drug Sales by Application (2021-2026) & (Kiloton)
Table 130. Direct Channel Pros & Cons
Table 131. Indirect Channel Pros & Cons
Table 132. C Difficile Infection Drug Typical Distributors
Table 133. C Difficile Infection Drug Typical Customers
List of Figures
Figure 1. C Difficile Infection Drug Picture
Figure 2. Global C Difficile Infection Drug Sales Market Share by Type in 2020
Figure 3. Metronidazole
Figure 4. Vancomycin
Figure 5. Fidaxomycin
Figure 6. Others
Figure 7. Global C Difficile Infection Drug Sales Market Share by Application in 2020
Figure 8. Pre-treatment
Figure 9. Mid-term treatment
Figure 10. Others
Figure 11. Global C Difficile Infection Drug Market Size, (USD Million) & (Kiloton): 2020 VS 2021 VS 2026
Figure 12. Global C Difficile Infection Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global C Difficile Infection Drug Sales (2016-2026) & (Kiloton)
Figure 14. Global C Difficile Infection Drug Price by Type (2016-2026) & (US$/Ton)
Figure 15. Global C Difficile Infection Drug Production Capacity (2016-2026) & (Kiloton)
Figure 16. Global C Difficile Infection Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. C Difficile Infection Drug Market Drivers
Figure 18. C Difficile Infection Drug Market Restraints
Figure 19. C Difficile Infection Drug Market Trends
Figure 20. Global C Difficile Infection Drug Sales Market Share by Manufacturer in 2020
Figure 21. Global C Difficile Infection Drug Revenue Market Share by Manufacturer in 2020
Figure 22. C Difficile Infection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 C Difficile Infection Drug Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 C Difficile Infection Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Global C Difficile Infection Drug Sales Market Share by Region (2016-2026)
Figure 26. Global C Difficile Infection Drug Revenue Market Share by Region (2016-2026)
Figure 27. North America C Difficile Infection Drug Revenue (2016-2026) & (USD Million)
Figure 28. Europe C Difficile Infection Drug Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific C Difficile Infection Drug Revenue (2016-2026) & (USD Million)
Figure 30. South America C Difficile Infection Drug Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa C Difficile Infection Drug Revenue (2016-2026) & (USD Million)
Figure 32. Global C Difficile Infection Drug Sales Market Share by Type (2016-2026)
Figure 33. Global C Difficile Infection Drug Revenue Market Share by Type (2016-2026)
Figure 34. Global C Difficile Infection Drug Price by Type (2016-2026) & (US$/Ton)
Figure 35. Global C Difficile Infection Drug Sales Market Share by Application (2016-2026)
Figure 36. Global C Difficile Infection Drug Revenue Market Share by Application (2016-2026)
Figure 37. Global C Difficile Infection Drug Price by Application (2016-2026) & (US$/Ton)
Figure 38. North America C Difficile Infection Drug Sales Market Share by Type (2016-2026)
Figure 39. North America C Difficile Infection Drug Sales Market Share by Application (2016-2026)
Figure 40. North America C Difficile Infection Drug Sales Market Share by Country (2016-2026)
Figure 41. North America C Difficile Infection Drug Revenue Market Share by Country (2016-2026)
Figure 42. United States C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe C Difficile Infection Drug Sales Market Share by Type (2016-2026)
Figure 46. Europe C Difficile Infection Drug Sales Market Share by Application (2016-2026)
Figure 47. Europe C Difficile Infection Drug Sales Market Share by Country (2016-2026)
Figure 48. Europe C Difficile Infection Drug Revenue Market Share by Country (2016-2026)
Figure 49. Germany C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific C Difficile Infection Drug Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific C Difficile Infection Drug Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific C Difficile Infection Drug Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific C Difficile Infection Drug Revenue Market Share by Region (2016-2026)
Figure 58. China C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America C Difficile Infection Drug Sales Market Share by Type (2016-2026)
Figure 65. South America C Difficile Infection Drug Sales Market Share by Application (2016-2026)
Figure 66. South America C Difficile Infection Drug Sales Market Share by Country (2016-2026)
Figure 67. South America C Difficile Infection Drug Revenue Market Share by Country (2016-2026)
Figure 68. Brazil C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa C Difficile Infection Drug Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa C Difficile Infection Drug Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa C Difficile Infection Drug Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa C Difficile Infection Drug Revenue Market Share by Country (2016-2026)
Figure 74. Turkey C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa C Difficile Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の腸内細菌科感染症薬市場 2021：企業別、地域別、種類・用途別 The Enterobacteriaceae Infection Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- 尿路感染症治療市場：世界及び中国市場分析・予測（～2024年） Urinary Tract Infection Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Urinary Tract Infection Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ur…
- 世界のマールブルグウイルス感染症市場 2021：企業別、地域別、種類・用途別 The Marburgvirus Infection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界の薬物中毒治療市場 2021：企業別、地域別、種類・用途別 The Drug Addiction Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の感染管理歯科用消耗品市場 2021：企業別、地域別、種類・用途別 The Infection Control Dental Consumables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …